Department of Pharmaceutical Chemistry, Philipps-University Marburg, Marbacher Weg 6, D-35032 Marburg, Germany.
Macromolecular Crystallography, Helmholtz-Zentrum Berlin, Albert-Einstein-Straße 15, D-12489 Berlin, Germany.
Acta Crystallogr D Struct Biol. 2021 Sep 1;77(Pt 9):1168-1182. doi: 10.1107/S2059798321008196. Epub 2021 Aug 23.
In recent years, crystallographic fragment screening has matured into an almost routine experiment at several modern synchrotron sites. The hits of the screening experiment, i.e. small molecules or fragments binding to the target protein, are revealed along with their 3D structural information. Therefore, they can serve as useful starting points for further structure-based hit-to-lead development. However, the progression of fragment hits to tool compounds or even leads is often hampered by a lack of chemical feasibility. As an attractive alternative, compound analogs that embed the fragment hit structurally may be obtained from commercial catalogs. Here, a workflow is reported based on filtering and assessing such potential follow-up compounds by template docking. This means that the crystallographic binding pose was integrated into the docking calculations as a central starting parameter. Subsequently, the candidates are scored on their interactions within the binding pocket. In an initial proof-of-concept study using five starting fragments known to bind to the aspartic protease endothiapepsin, 28 follow-up compounds were selected using the designed workflow and their binding was assessed by crystallography. Ten of these compounds bound to the active site and five of them showed significantly increased affinity in isothermal titration calorimetry of up to single-digit micromolar affinity. Taken together, this strategy is capable of efficiently evolving the initial fragment hits without major synthesis efforts and with full control by X-ray crystallography.
近年来,晶体学碎片筛选技术已经在几个现代同步辐射站点成熟为几乎常规的实验。筛选实验的命中物,即与靶蛋白结合的小分子或片段,伴随着其 3D 结构信息被揭示出来。因此,它们可以作为进一步基于结构的命中物到先导化合物发展的有用起点。然而,片段命中物向工具化合物甚至先导化合物的进展常常受到化学可行性的限制。作为一种有吸引力的替代方案,可以从商业目录中获得结构上嵌入片段命中物的化合物类似物。在这里,报告了一种基于模板对接来筛选和评估此类潜在后续化合物的工作流程。这意味着晶体学结合构象被整合到对接计算中作为中央起始参数。随后,根据它们在结合口袋中的相互作用对候选物进行评分。在使用已知与天冬氨酸蛋白酶内切酶结合的五个起始片段的初步概念验证研究中,使用设计的工作流程选择了 28 个后续化合物,并通过晶体学评估了它们的结合。其中 10 种化合物结合到活性位点,其中 5 种在等温滴定量热法中显示出显著增加的亲和力,可达单位数微摩尔亲和力。总的来说,这种策略能够在不进行大量合成工作的情况下有效地进化初始片段命中物,并通过 X 射线晶体学进行完全控制。